China Preventive Inhaler Market Size, Industry Trends, Share and Forecast 2019-2025
China preventive inhaler market is anticipated to grow at a substantial CAGR of around 3.5% during the forecast period. High level of air pollution and the significant number of smokers in China is boosting the demand for preventive inhalers in the country. Additionally, the rising geriatric population susceptible to asthma and COPD within the country is also driving the demand for preventive inhalers. From June 2012 to May 2015, a survey was conducted by the Ministry of Health and Ministry of Science and Technology of China. About 51,000 citizens participated in the survey with 21,500 men and 29,500 women, according to which, it was estimated that about 100 million adults in 2015 had the problem of COPD in the country. The prevalence is higher in men as compared to women. As per the estimation, there were 68.4 million men and 31.5 million women affected by COPD.
To Request a Sample of our Report on China
Preventive Inhaler Market: https://www.omrglobal.com/request-sample/china-preventive-inhaler-market
The China preventive inhaler market
is segmented on the basis of device type, application, and end-user. On the
basis of the device, the market is sub-segmented into the metered dosed inhaler
and dry powdered inhaler. The dry powder preventive inhaler is estimated to
have the largest market share in the China preventive inhaler market due to
providing an easy inhalation solution. Whereas, the market for metered dose
preventive inhaler is estimated to be the fastest-growing at a CAGR during the
forecast period owing to innovations and collaborations by the companies for
the development of metered dosed inhaler. Moreover, on the basis of
application, the market has been classified into asthma and COPD diseases. In
addition, based on the end-user, homecare and hospitals and clinics have been
analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of China Preventive Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/china-preventive-inhaler-market
China Preventive
Inhaler Market Segmentation
By Device Type
·
Metered Dose Inhaler
·
Dry Powder Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
Aradigm Corp.
·
AstraZeneca PLC
·
Boehringer Ingelheim International GmbH
·
Cipla Ltd.
·
GlaxoSmithKline PLC
·
Koninklijke Philips N.V.
·
MidasCare Pharmaceutical Pvt. Ltd.
·
Novartis AG
·
Omron Healthcare Inc.
·
Sunovion Pharmaceuticals
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment